A Combinatorial CRISPR-Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment.
Xu F, Tong M, Tong CSW, Chan BKC, Chu HY, Wong TL, Fong JHC, Cheung MSH, Mak KH, Pardeshi L, Huang Y, Wong KH, Choi GCG, Ma S, Wong ASL.
Xu F, et al. Among authors: huang y.
Cancer Res. 2021 Dec 15;81(24):6219-6232. doi: 10.1158/0008-5472.CAN-21-1017. Epub 2021 Oct 19.
Cancer Res. 2021.
PMID: 34666996